ArticleCureus2025
Systemic Bacillus Calmette-Guérin (BCG) Infection in a Patient With Non-Muscle-Invasive Bladder Cancer: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravesical Bacillus Calmette-Guérin (BCG) instillation is a widely used adjuvant therapy for non-muscle-invasive bladder cancer (NMIBC), typically associated with a favorable safety profile. However, severe complications such as systemic BCG infection, though rare, can occur and are potentially life-threatening. Diagnosing systemic BCG infection is challenging due to frequently negative microbiological results. We report the case of a 67-year-old immunocompetent man who developed a systemic BCG infection after undergoing BCG therapy for NMIBC. Initially misdiagnosed as a urinary tract infection, his condition worsened despite antibiotic treatment. The diagnosis of BCG sepsis was suspected after prolonged fever, asthenia, and other systemic symptoms. Prompt initiation of antituberculosis treatment with rifampicin, ethambutol, and isoniazid led to a full recovery. This case underscores the critical importance of early recognition and treatment of systemic BCG infections, particularly in patients presenting with persistent fever and no clear source of infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.